Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors

[1]  J. Nakae,et al.  Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. , 1998, The Journal of clinical endocrinology and metabolism.

[2]  YujiMatsuzawa,et al.  High Concentration of Glucose Increases Mitogenic Responsiveness to Heparin-Binding Epidermal Growth Factor–like Growth Factor in Rat Vascular Smooth Muscle Cells , 1997 .

[3]  Y. Nikiforov,et al.  Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. , 1997, The Journal of clinical investigation.

[4]  E. Araki,et al.  Impact of Natural IRS-1 Mutations on Insulin Signals: Mutations of IRS-1 in the PTB Domain and Near SH2 Protein Binding Sites Result in Impaired Function at Different Steps of IRS-1 Signaling , 1997, Diabetes.

[5]  E. Araki,et al.  Cell-Specific Regulation of IRS-1 Gene Expression: Role of E Box and C/EBP Binding Site in HepG2 Cells and CHO Cells , 1997, Diabetes.

[6]  S. Amselem,et al.  Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor. , 1996, Metabolism: clinical and experimental.

[7]  R. Bergman,et al.  Insulin Sensitivity and Atherosclerosis , 1996 .

[8]  M. Kawakami,et al.  Enhanced Expression of Platelet-Derived Growth Factor-β Receptor by High Glucose Involvement of Platelet-Derived Growth Factor in Diabetic Angiopathy , 1996, Diabetes.

[9]  J. Wands,et al.  Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases , 1996, Molecular and cellular biology.

[10]  Y. Matsuzawa,et al.  Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[11]  H. Benecke,et al.  Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors (*) , 1995, The Journal of Biological Chemistry.

[12]  G. Lienhard,et al.  Transforming potential of the insulin receptor substrate 1. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  C. Kahn,et al.  Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells. , 1995, Endocrinology.

[14]  R. Baserga,et al.  The insulin-like growth factor I receptor: a key to tumor growth? , 1995, Cancer research.

[15]  R. Baserga.  Oncogenes and the strategy of growth factors , 1994, Cell.

[16]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[17]  M. White,et al.  The IRS-1 signaling system. , 1994, Trends in biochemical sciences.

[18]  C. Kahn,et al.  Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. , 1994, Molecular endocrinology.

[19]  C. Kahn,et al.  Cloning of the mouse insulin receptor substrate-1 (IRS-1) gene and complete sequence of mouse IRS-1. , 1994, Biochimica et biophysica acta.

[20]  D. Accili,et al.  Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. , 1994, The EMBO journal.

[21]  G. Striker,et al.  Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. , 1993, Endocrinology.

[22]  C. Kahn,et al.  Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Nagataki,et al.  Trial of Insulinlike Growth Factor I Therapy for Patients With Extreme Insulin Resistance Syndromes , 1993, Diabetes.

[24]  M. White,et al.  The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains , 1993, Diabetes.

[25]  C. W. Garner,et al.  Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. , 1993, Biochemical and biophysical research communications.

[26]  M J Saad,et al.  Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. , 1992, The Journal of clinical investigation.

[27]  G. Lienhard,et al.  Regulation of the expression of pp160, a putative insulin receptor signal protein, by insulin, dexamethasone, and 1-methyl-3-isobutylxanthine in 3T3-L1 adipocytes. , 1992, The Journal of biological chemistry.

[28]  R. Klein,et al.  Association of Elevated IGF-I Levels With Increased Retinopathy in Late-Onset Diabetes , 1991, Diabetes.

[29]  D. Brown,et al.  Effects of IGF-I and Glucose on Protein and Proteoglycan Synthesis by Human Fetal Mesangial Cells in Culture , 1991, Diabetes.

[30]  I. Pastan,et al.  Cytotoxic Effects of a Recombinant Chimeric Toxin on Rapidly Proliferating Vascular Smooth Muscle Cells , 1991, Circulation.

[31]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[32]  J. Flier,et al.  Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant. , 1991, The Journal of biological chemistry.

[33]  S. Rosenzweig,et al.  Regulation of insulin-like growth factor I receptors in diabetic mesangial cells. , 1991, The Journal of biological chemistry.

[34]  B. Burguera,et al.  Experimental Diabetes Increases Insulinlike Growth Factor I and II Receptor Concentration and Gene Expression in Kidney , 1990, Diabetes.

[35]  A. Maccuish,et al.  Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome. , 1990, The New England journal of medicine.

[36]  J. Flier,et al.  A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. , 1990, The Journal of biological chemistry.

[37]  S. Haffner,et al.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.

[38]  J. Olefsky,et al.  Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors. , 1990, The Journal of biological chemistry.

[39]  G. King,et al.  Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Sherwin,et al.  Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. , 1989, The Journal of clinical investigation.

[41]  C. Kahn,et al.  The insulin receptor and the molecular mechanism of insulin action. , 1988, The Journal of clinical investigation.

[42]  O. Rosen.  After insulin binds. , 1987, Science.

[43]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[44]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[45]  C. Kahn,et al.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.

[46]  D. Clemmons,et al.  Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. , 1985, The Journal of clinical investigation.

[47]  E. Froesch,et al.  Insulin-like growth factors. Studies in diabetics with and without retinopathy. , 1983, The New England journal of medicine.

[48]  T. Dornan,et al.  PLASMA SOMATOMEDIN ACTIVITY AND DIABETIC RETINOPATHY , 1983, Clinical endocrinology.

[49]  西山 正輝.  Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma , 1994 .